ClinicalTrials.gg
Sign In

Drug

HRS-2189 clinical trials

Also written HRS-2189.

studies test it
4
open now
3
in phase 3
0
first study started
2023

Keep track of what changes. Save the HRS-2189 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

HRS-2189
2

Studies by the year they started

4 studies that test it; most in 2023 (1)

Studies that test HRS-2189, by start year
YearStudies
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Prostatic Neoplasms
1
Neoplasms
1

Who runs them

Industry 2 · Other 2

Shandong Suncadia Medicine Co., Ltd. (2) · Fudan University (2)

Often tested with

Tested in the same studies.

Adebrelimab (1) · BP102 (1) · Bevacizumab (1) · HRS-5041 (1)

Studies

Open first, then newest update. How each study uses HRS-2189 is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 3 — HRS-2189 is usual care beside what is tested